Gilead hepatitis C drug shows promise in late-stage trial

Tue Nov 27, 2012 8:06pm IST

Related Topics

Stocks

   
Priyanka Gandhi Vadra, daughter of Congress party chief Sonia Gandhi, adjusts her flower garlands as she campaigns for her mother during an election meeting at Rae Bareli in Uttar Pradesh April 22, 2014. REUTERS/Pawan Kumar

Election 2014

More than 814 million people — a number larger than the population of Europe — are eligible to vote in the world’s biggest democratic exercise.  Full Coverage 

(Reuters) - Gilead Sciences said a late-stage trial of its experimental hepatitis C treatment showed that the virus was not detected in 78 percent of patients taking the drug, 12 weeks after completing therapy.

The trial, named Positron, was testing the drug, sofosbuvir, in patients who were unable or unwilling to take interferon -- a standard hepatitis C drug known for its unpleasant side effects.

No patient in the placebo group achieved an undetectable virus level 12 weeks after completing the therapy, Gilead said.

The safety profile of the drug was similar to that observed in prior studies, and there were few treatment discontinuations due to adverse events, Gilead said.

The company said it would submit the full data from the study for presentation at a scientific conference and will share data from additional late-stage studies in early 2013.

Gilead expects to submit its first regulatory filings for sofosbuvir by mid-2013, Chief Scientific Officer Norbert Bischofberger said.

(Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Fighting TB

REUTERS SHOWCASE

Only For Adults

Only For Adults

FDA moves to ban sales of e-cigarettes to minors.  Full Article 

For Diabetics

For Diabetics

Weight loss plan better than usual diet for diabetes patients.  Full Article 

Depends On DNA

Depends On DNA

Aspirin's benefit in preventing colon cancer depends on DNA.  Full Article 

STD Risk

STD Risk

Could shared sex toys transmit HPV?  Full Article 

Marijuana Use

Marijuana Use

France sees small increase in pot-related heart problems.  Full Article 

Internet Effect

Internet Effect

Retirees who use the Internet less likely to be depressed: study.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage